These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4910040)

  • 1. [Vincaleukoblastine in the therapy of malignant neoplasms].
    Rotolo V
    Friuli Med; 1968; 23(1):31-52. PubMed ID: 4910040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
    Zarrilli D; Perrone V; Pergola M
    Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of large single doses of cyclophosphane (endoxan)].
    Garin AM
    Vopr Onkol; 1970; 16(11):43-8. PubMed ID: 4929048
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polychemotherapy of malignant tumors and hemoblastoses].
    Kühböck J; Pokorny D; Steinbach K; Eggerth G
    Wien Z Inn Med; 1968; 49(12):449-61. PubMed ID: 4311394
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immediate results of the clinical use of bruneomycin].
    Akop'iants SS
    Antibiotiki; 1968 Jan; 13(1):84-7. PubMed ID: 4873978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with the cytostatic podophyllin therapy].
    Halama J
    Munch Med Wochenschr; 1967 Feb; 108(7):378-81. PubMed ID: 4862314
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids.
    Carbone PP; Spurr C; Schneiderman M; Scotto J; Holland JF; Shnider B
    Cancer Res; 1968 May; 28(5):811-22. PubMed ID: 4870882
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of vinblastine for maintenance therapy in malignant lymphomas.
    Klener P; Donner L; Ort J
    Neoplasma; 1974; 21(3):323-9. PubMed ID: 4608740
    [No Abstract]   [Full Text] [Related]  

  • 10. Vinblastine treatment of malignant lymphomas.
    Klener P; Donner L; Neuwirtová R; Ort J
    Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of cancer patients with a compression mediastinal syndrome].
    Zmeul VK
    Vopr Onkol; 1971; 17(11):90-2. PubMed ID: 4945609
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigations with 1,4-bis-(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol (R-74).
    Hindy I; Sellei C; Eckhardt S; Szentklãray J; Hartai F
    Neoplasma; 1971; 18(3):277-82. PubMed ID: 4937513
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine.
    Armstrong JG; Dyke RW; Fouts PJ; Hawthorne JJ; Jansen CJ; Peabody AM
    Cancer Res; 1967 Feb; 27(2):221-7. PubMed ID: 5335120
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with vinblastine in the treatment of lymphoblastomas].
    Capretti G
    Cancro; 1968; 21():Suppl 6:93-7. PubMed ID: 4906146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience in the treatment of malignant lymphomas with Vinca rosea alkaloids].
    Prato V; Mazza U; Uslenghi E; Battistini V; Bianco G
    Cancro; 1968; 21():Suppl 6:79-85. PubMed ID: 4906145
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of lymphoma with mechlorethamine and vinblastine.
    Solomon J; Jacobs EM; Bateman JR; Lukes RJ; Weiner JM; Donohue DM
    Arch Intern Med; 1973 Mar; 131(3):407-17. PubMed ID: 4569376
    [No Abstract]   [Full Text] [Related]  

  • 17. How to use cancer chemotherapy.
    Dollinger MR
    Am Fam Physician; 1971 Jun; 3(6):73-84. PubMed ID: 4325596
    [No Abstract]   [Full Text] [Related]  

  • 18. [High-dosed cyclophosphamide therapy of malignant diseases of the lymphoreticulum].
    Kühböck J; Pietschmann H
    Wien Klin Wochenschr; 1965 Nov; 77(44):883-6. PubMed ID: 5328863
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with N-Lost phosphamide esters].
    Drings P; Allner R; Brock N; Burkert H; Fischer M; Fölsch E; Gerhartz H; Götzky P; Hoppe I; Kanzler G; Klein HO; Mainzer K; Martin H; Obrecht P; Palme G; Paulisch H; Riegg H; Schubert JC; Treske U; Weise W; Willems D; Wilmanns H; Witte S; Wohlenberg H
    Dtsch Med Wochenschr; 1970 Mar; 95(10):491-7. PubMed ID: 4905291
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes of oxyindole acetic acid excretion and the thrombocyte count under the influence of Zitofenton.
    Masszi F; Máté-Wójcińska U
    Neoplasma; 1965; 12(6):629-33. PubMed ID: 5324521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.